High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer

Adjuvant chemotherapy (ACT) is usually used to reduce the risk of disease relapse and improve survival for stage II/III colorectal cancer (CRC). However, only a subset of patients could benefit from ACT. Thus, there is an urgent need to identify improved biomarkers to predict survival and stratify p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Shu-Biao, Cheng, Yi-Kan, Li, Pei-Si, Zhang, Lin, Zhang, Lian-Hai, Huang, Yan, Chen, Ping, Wang, Yi, Wang, Chao, Peng, Jian-Hong, Shi, Li-Shuo, Ling, Li, Wu, Xiao-Jian, Qin, Jun, Yang, Zi-Huan, Lan, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232411/
https://www.ncbi.nlm.nih.gov/pubmed/37258779
http://dx.doi.org/10.1038/s41698-023-00400-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232411/
https://www.ncbi.nlm.nih.gov/pubmed/37258779
http://dx.doi.org/10.1038/s41698-023-00400-0

Ejemplares similares